Innate Pharma SA announces its financial results for 2007: Moderate burn rate in the context of continuing clinical effort and pipeline maturation.
| PR in english | 73.85 KB |
| CP en français | 77.72 KB |
| Slideshow in english | 385.46 KB |
Innate Pharma SA announces its financial results for 2007: Moderate burn rate in the context of continuing clinical effort and pipeline maturation.
| PR in english | 73.85 KB |
| CP en français | 77.72 KB |
| Slideshow in english | 385.46 KB |